Cell-derived exosomes have opened new horizons in modern therapy for advanced drug
delivery and therapeutic applications, due to their key features such as low immunogenicity …

In the past decade, extracellular vesicles (EVs) have emerged as a key cell-free strategy for
the treatment of a range of pathologies, including cancer, myocardial infarction, and …

Increasing evidences show that unmodified extracellular vesicles (EVs) derived from various
cells can effectively inhibit the malignant progression of different types of tumors by …

The iron oxide nanoparticles (IONPs), possessing both magnetic behavior and
semiconductor property, have been extensively used in multifunctional biomedical fields due …

Extracellular vesicles (EVs) are emerging as promising nanoscale therapeutics due to their
intrinsic role as mediators of intercellular communication, regulating tissue development and …

The great demand for tissue and organ grafts, compounded by an aging demographic and a
shortage of available donors, has driven the development of bioengineering approaches …

Great strides have been taken towards the in vitro engineering of clinically relevant tissue
constructs using the classic triad of cells, materials, and biochemical factors. In this …

Ultra-small-sized iron oxide nanoparticles with good biocompatibility are regarded as
promising alternatives for the gadolinium-based contrast agents, which are widely used as a …

Exosomes secrete from various cells and can be separated from all biological fluids, which
possess the properties of their origin, and function as cell communication. Moreover, the …

Ferumoxytol, which is originally intended for MRI and anemia treatment, is currently the only
inorganic nanodrug approved by FDA for clinical application in vivo. Common ferumoxytol …